| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |